CoChat

Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025)

Open access
Mehany, Olivia, Artner, Anna, Sebők, Szilvia, Hankó, Balázs, Zelkó, Romána · 2026 · Journal of Clinical Medicine

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 54 of the 100 sources its claims cite were checked for support.

Abstract

Objectives: Medication adherence in elderly patients is shaped by cognitive, behavioral, systemic, and socioeconomic factors. This review aimed to identify determinants and effective strategies to improve adherence in older adults. Methods: A systematic search of PubMed, Scopus, and ScienceDirect (2015–2025) followed PRISMA 2020 guidelines. From 5116 records, 53 studies met inclusion criteria. Randomized controlled trials were meta-analyzed using standardized mean differences under a random-effects model. Risk of bias in the 10 pooled trials was assessed using the Cochrane RoB 2 tool, and certainty of evidence was evaluated using the GRADE framework. Results: Adherence ranged from 25.3% in institutionalized patients to 97.6% in pharmacist-led schizophrenia programs. Cognitive impairment and frailty reduced adherence (54.2%), while caregiver involvement improved rates, especially in dementia and schizophrenia (77.4–97.6%). Socioeconomic barriers, including medication cost, contributed to nonadherence but were mitigated by subsidies. Digital tools enhanced adherence in chronic disease, and machine learning models accurately predicted nonadherence (AUC up to 0.935). Effective interventions—caregiver support, digital platforms, and single-pill regimens—increased adherence by 25–59% and reduced cardiovascular events. The meta-analysis demonstrated a significant pooled effect (Standardized Mean Difference, SMD = 0.71, 95% CI: 0.11–1.54), although heterogeneity was high (I2 = 99%). The RoB 2 assessment of the 10 pooled trials identified 2 at low risk, 4 with some concerns, and 4 at high risk of bias; the GRADE certainty of evidence was rated Very Low. Conclusions: Multiple factors, including frailty, cognitive deficits, socioeconomic barriers, regimen complexity, and the level of caregiver support, appear to be consistently associated with medication adherence in older adults. Strategies such as caregiver engagement, digital health tools, regimen simplification, and mental health support may contribute to improved adherence, although effect sizes vary considerably across study contexts. Given the substantial heterogeneity, Very Low certainty of evidence (GRADE), and variable study quality, findings should be interpreted with caution. System-level reforms, financial assistance programs, and culturally tailored approaches may further support adherence, while the successful implementation of digital health solutions will require addressing literacy, accessibility, and integration challenges.

Overview

CoChat Summary

## TL;DR

This systematic review and meta-analysis found that medication-adherence interventions for older adults generally favored the intervention arm, with a pooled standardized mean difference of 0.71 (95% CI: 0.11–1.54) across 10 trials. However, the evidence was rated Very Low certainty because of very high heterogeneity (I2 = 99%) and substantial risk of bias.

## Key findings

  • The search identified 5,116 records; after screening and full-text review, 53 studies were included in the systematic review, and 10 trials with extractable adherence data were pooled in the meta-analysis (combined N = 3,733).
  • The pooled meta-analytic effect was significant: SMD = 0.71 (95% CI: 0.11–1.54), but heterogeneity was very high (I2 = 99%).
  • Risk of bias among the 10 pooled trials was mixed: 2 were rated low risk, 4 had some concerns, and 4 were high risk.
  • Subgroup summaries all favored intervention: digital/e-health interventions (6 trials), caregiver-supported/educational strategies (2 trials), and pharmacological/regimen-level interventions (3 trials), with the largest reported SMDs in digital interventions (0.08 to 2.31) and more modest effects for pharmacological/management interventions (−0.05 to 0.32).

## Methods

  • Systematic review and meta-analysis following PRISMA 2020, with searches of PubMed, Scopus, and ScienceDirect for English-language human studies published from 2015–2025.
  • Included English-language, peer-reviewed original research reporting quantitative medication-adherence outcomes in older adults; 53 studies met criteria, and 10 randomized or quasi-experimental trials were pooled.
  • Effect sizes were converted to standardized mean differences (Hedges g) and analyzed in RevMan 5.3 using an inverse-variance random-effects model; risk of bias was assessed with Cochrane RoB 2, and certainty with GRADE.

## Limitations

  • The paper states the overall certainty of evidence was Very Low because of serious risk of bias, very serious inconsistency, and high heterogeneity (I2 = 99%).
  • The authors note that only 10 studies were eligible for pooling, which prevented formal meta-regression and funnel-plot assessment; selective outcome reporting remains a plausible concern.
  • Evident from the text: many included studies relied on self-reported adherence, and the non-interventional studies were mostly cross-sectional, observational, small convenience samples with limited confounder adjustment, which weakens the qualitative synthesis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jcm15052069

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Determinants of Medication Adherence in Elderly People: A Multifactorial Framework.
Figure 1 Determinants of Medication Adherence in Elderly People: A Multifactorial Framework.CC BY · PubMed Central
Figure 2 PRISMA-2020 flow diagram of study selection process for systematic review on medication adherence.
Figure 2 PRISMA-2020 flow diagram of study selection process for systematic review on medication adherence.CC BY · PubMed Central
Figure 3 Visual summary of standardized mean differences (SMDs) across included studies. Green signs represent the effect estimates of individual studies, while the black diamond represents the pooled effect with its 95% confidence interval.
Figure 3 Visual summary of standardized mean differences (SMDs) across included studies. Green signs represent the effect estimates of individual studies, while the black diamond represents the pooled effect with its 95% confidence interval.CC BY · PubMed Central

Verification

Claims the paper makes

45 Valid · 7 Not valid · 42 Not checked · 57 Own results and interpretations

78 more claims · 31 with their cited sources checked

Create a free account to see all 151 claims and to verify the 12 references still open.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 46
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Research works printed but not linked: 1

  1. Lee, 2018, Optimizing medications in older adults with cognitive impairment, Can. Fam. Phys., 64, 646

Cited by

See all 6

Metadata

Authors
Mehany, O., Artner, A., Sebők, S., Hankó, B., & Zelkó, R.
Affiliations
Semmelweis University (HU)
Corresponding author
Zelkó, Romána
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2026-03-09
Volume
15
Issue
5
Pages
2069
ISSN
2077-0383 (ISSN-L)
OpenAlex
W7134246012
Cited by
6
References
43
Citations by year
2026: 6
FWCI
12.33
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
Keywords
medication adherence, older adults, multilevel interventions, cognitive impairment, frailty, caregiver involvement, socioeconomic barriers, drug costs, digital health tools, regimen simplification, pharmacist intervention, dementia, schizophrenia, institutionalized patients, cardiovascular events, financial assistance programs, cultural tailoring, mental health support, predictors of adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.